Sara Ramaker

Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder.

D. Palumbo, P. Chappell, S. Wigal, 2020, Journal of child and adolescent psychopharmacology.

Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder

R. Findling, R. Abbas, D. Wajsbrot, 2017, Journal of child and adolescent psychopharmacology.

Safety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder.

R. Findling, J. Groark, Sara Ramaker, 2014, Journal of child and adolescent psychopharmacology.

Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension Trials

S. R. Jones, D. Wajsbrot, Sara Ramaker, 2018, CNS Spectrums.

Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Children and Adolescents with Major Depressive Disorder.

R. Findling, J. Groark, Sara Ramaker, 2016, Journal of child and adolescent psychopharmacology.

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder

K. Weihs, R. Abbas, D. Wajsbrot, 2017, Journal of child and adolescent psychopharmacology.

Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES).

J. Orazem, Y. Lokhnygina, P. Chappell, 2023, Journal of child and adolescent psychopharmacology.

Sertraline Pediatric Registry for the Evaluation of Safety: Design and Clinical Characteristics of Pediatric Patients Prescribed Sertraline.

J. Orazem, Y. Lokhnygina, P. Chappell, 2021, Journal of child and adolescent psychopharmacology.